Mississippi House Bill HB1712

Mississippi 2026 Regular Session

• Introduced: 1/19/26
• Refer: 1/19/26
• Failed: 2/3/26

Caption

Kratom; add to Schedule III of the Uniform Controlled Substances Act.

Impact

If enacted, HB 1712 would have significant implications for the regulation of kratom in Mississippi. The classification of kratom as a Schedule III substance would mean that its production, distribution, and use would be restricted, requiring a prescription for legal access. The bill could also lead to enforcement actions against those selling kratom without appropriate regulatory oversight, impacting retailers and consumers. Proponents argue that regulation will help prevent misuse and ensure consumer safety, while opponents may view it as an unnecessary restriction on a substance they believe poses minimal risk.

Summary

House Bill 1712 aims to amend the Mississippi Uniform Controlled Substances Act by adding kratom (Mitragyna speciosa) to Schedule III. This legislative change would classify kratom, along with its compounds, salts, and derivatives, as a controlled substance, thereby subjecting it to regulation and restriction within the state. The bill reflects a growing trend in various states to address the potential risks associated with the use of kratom, which has been under scrutiny for its psychoactive properties and potential health effects.

Contention

Debate surrounding HB 1712 is anticipated, as there are vocal proponents and opponents of regulating kratom. Advocates for regulation argue that adding it to the controlled substances list will help mitigate public health risks, especially considering reports of adverse health effects associated with kratom use. Conversely, advocates for the freedom to use kratom present arguments about natural substances and personal choice, often citing its use in traditional medicine as a mitigative tool for pain and other issues. Therefore, the conversation is likely to revolve around the balance between public health safety and individual liberties.